Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
988
datasets available to search
ShareScore release 0.9.0
Dataset results
988 results for “platinum”
Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum
ClinicalTrials.gov study NCT01355497. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)
ClinicalTrials.gov study NCT01891344. IPD Sharing: Not stated. Countries: 6. Publications: 5.
A Study of Pembrolizumab and Olaparib for People With Metastatic Pancreatic Ductal Adenocarcinoma and Homologous Recombination Deficiency or Exceptional Treatment Response to Platinum-Based Therapy
ClinicalTrials.gov study NCT04666740. IPD Sharing: YES. Countries: 1. Publications: 1.
Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer
ClinicalTrials.gov study NCT00090610. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Sintilimab in Combination With Gemcitabine and Platinum-Based Chemotherapy as First-Line Therapy for Advanced or Metastatic Squamous NSCLC
ClinicalTrials.gov study NCT03629925. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Maintenance Rucaparib in BRCA1, BRCA2 or PALB2 Mutated Pancreatic Cancer That Has Not Progressed on Platinum-based Therapy
ClinicalTrials.gov study NCT03140670. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of Pembrolizumab in Subjects With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Who Progressed After First-Line Therapy With Platinum and Fluoropyrimidine: Integration of Molecula
ClinicalTrials.gov study NCT02589496. IPD Sharing: YES. Countries: 1. Publications: 0.
Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors
ClinicalTrials.gov study NCT02499952. IPD Sharing: NO. Countries: 1. Publications: 1.
Alectinib Versus Pemetrexed or Docetaxel in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Participants Previously Treated With Platinum-Based Chemotherapy and C
ClinicalTrials.gov study NCT02604342. IPD Sharing: Not stated. Countries: 15. Publications: 2.
A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)
ClinicalTrials.gov study NCT03459846. IPD Sharing: YES. Countries: 7. Publications: 1.
Clinical Trial of Lurbinectedin (PM01183) in Platinum Resistant Ovarian Cancer Patients
ClinicalTrials.gov study NCT02421588. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Niraparib + Ipilimumab or Nivolumab in Progression Free Pancreatic Adenocarcinoma After Platinum-Based Chemotherapy
ClinicalTrials.gov study NCT03404960. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy (POD1UM-202)
ClinicalTrials.gov study NCT03597295. IPD Sharing: NO. Countries: 9. Publications: 1.
A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site
ClinicalTrials.gov study NCT03498521. IPD Sharing: YES. Countries: 33. Publications: 1.
Trial With Cetuximab in Maintenance Therapy After Platinum Based Chemotherapy in First Line Treatment of Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00820755. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-smal
ClinicalTrials.gov study NCT03425643. IPD Sharing: YES. Countries: 25. Publications: 4.
p53 Activation in Platinum-Resistant High Grade Serous Ovarian Cancer, a Study of PLD With APR-246
ClinicalTrials.gov study NCT03268382. IPD Sharing: Not stated. Countries: 3. Publications: 2.
A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
ClinicalTrials.gov study NCT04296890. IPD Sharing: Not stated. Countries: 11. Publications: 3.
Exercise and Nutrition Interventions for Platinum Chemotherapy-induced Neuropathy R21
ClinicalTrials.gov study NCT05452902. IPD Sharing: YES. Countries: 1. Publications: 1.
Cabozantinib for Advanced or Metastatic Cervical Carcinoma After Platinum Treatment Failure
ClinicalTrials.gov study NCT04205799. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.